AstraZeneca partners with Oracle for AI-driven clinical trials阿斯利康与甲骨文合作开展人工智能驱动的临床试验
Oct 20 (Reuters) - AstraZeneca said on Tuesday that it is working with Oracle to use AI and real-world data to identify eligible patients for clinical trials and monitor safety signals, among other measures, as the drugmaker looks to improve clinical research.
FILE PHOTO: A company logo is seen at the AstraZeneca site in Macclesfield, Britain, May 11, 2021. REUTERS/Phil Noble/File Photo
Oct 20 (Reuters) - AstraZeneca said on Tuesday that it is working with Oracle to use AI and real-world data to identify eligible patients for clinical trials and monitor safety signals, among other measures, as the drugmaker looks to improve clinical research.
• The collaboration will combine AstraZeneca's drug development expertise with Oracle's AI and healthcare data capabilities to support patient matching and research
Thank you for your report!
Proposed export curbs target advanced solar technologies
Samsung to use TSMC technology for Nvidia's next-generation memory chips, Seoul newspaper reports
India’s L&T Technology expects robust second half as deals ramp up; quarterly revenue rises
资料照片：2021年5月11日，英国麦克尔斯菲尔德阿斯利康公司厂区内可见公司标志。路透社/菲尔·诺布尔/资料照片
10 月 20 日（路透社）——阿斯利康周二表示，该公司正与 Oracle 合作，利用人工智能和真实世界数据来识别符合临床试验条件的患者，并监测安全信号等措施，以期改进临床研究。
• 此次合作将结合阿斯利康的药物研发专长和甲骨文的人工智能及医疗数据能力，以支持患者匹配和研究。
感谢您的报告！
拟议的出口限制措施针对先进太阳能技术
据首尔报纸报道，三星将采用台积电技术为英伟达生产下一代内存芯片。
印度L&T科技公司预计下半年业绩强劲增长，交易量将增加；季度营收也将上升。